OIW
- 产品代码
- OIW
- 器械名称
- Software, Similarity Score Algorithm, Tissue Of Origin For Malignant Tumor Types
- 管理类别
- 第 2 类(Class II)
- 21 CFR 条款
- 21 CFR 862.3100
- FDA 专业组
- Clinical Toxicology
- 上市路径
- 需提交 510(k) 上市前通告
- 标记
- 可走第三方审查
- FDA 历史累计 510(k)
- 4 件(全部年份;本站只收录近三年的明细)
FDA 分类定义
This test is intended to measure the degree of similarity between the RNA expression pattern in a patient?s fresh-frozen tumor and the RNA expression patterns in a database of tumor samples for some common malignant tumor types that were diagnosed according to then current clinical and pathological practice. The test result is intended for use in the context of the patient?s clinical history and other diagnostic tests evaluated by a qualified clinician. The test is not intended to establish the origin of tumors (e.g. carcinoma of unknown primary) that cannot be diagnosed according to current clinical and pathological practice.
FDA 官方分类页: OIW
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。